Regional Systems of Care to Optimize Outcomes in Patients Undergoing Transcatheter Aortic Valve Replacement

Autor: Anthony Della Siega, Anson Cheung, Karin H. Humphries, John G. Webb, May Lee, Jonathon Leipsic, Christopher R. Thompson, Sandra Lauck, Albert W. Chan, T. Latham, Daniel R. Wong, J. Charania, Dion Stub, J. Polderman, Simon D. Robinson, D. Dvir, Jian Ye, David A. Wood, Min Gao, Richard C. Cook
Rok vydání: 2015
Předmět:
Male
Cardiac Catheterization
Time Factors
medicine.medical_treatment
Valve replacement
Risk Factors
Interquartile range
Hospital Mortality
Prospective Studies
Registries
Myocardial infarction
Referral and Consultation
Stroke
Aged
80 and over

Heart Valve Prosthesis Implantation
Delivery of Health Care
Integrated

Process Assessment
Health Care

Quality Improvement
3. Good health
Treatment Outcome
Aortic Valve
Heart Valve Prosthesis
Cohort
transcatheter aortic valve replacement
Female
Health Services Research
Cardiology and Cardiovascular Medicine
medicine.medical_specialty
Transcatheter aortic
Risk Assessment
Regional Health Planning
medicine
Humans
Aged
Quality Indicators
Health Care

Patient Care Team
British Columbia
business.industry
Patient Selection
aortic stenosis
Aortic Valve Stenosis
Length of Stay
medicine.disease
Surgery
Stenosis
Models
Organizational

Emergency medicine
Observational study
business
Program Evaluation
Zdroj: JACC: Cardiovascular Interventions. 8(15):1944-1951
ISSN: 1936-8798
DOI: 10.1016/j.jcin.2015.09.017
Popis: Objectives This study sought to describe the development of a multicenter, transcatheter aortic valve replacement program and regional systems of care intended to optimize coordinated, efficient, and appropriate delivery of this new therapy. Background Transcatheter aortic valve replacement (TAVR) has become an accepted treatment option for patients with severe aortic stenosis who are at high surgical risk. Regional systems of care have led to improvements in outcomes for patients undergoing intervention for myocardial infarction, cardiac arrest, and stroke. We implemented a regional system of care for patients undergoing TAVR in British Columbia, Canada. Methods We describe a prospective observational cohort of 583 patients who underwent TAVR in British Columbia between 2012 and 2014. Regionalization of TAVR care in British Columbia refers to a centrally coordinated, funded, and evaluated program led by a medical director and a multidisciplinary advisory group that oversees planning, access to care, and quality of outcomes at the 4 provincial sites. Risk-stratified case selection for transfemoral TAVR is performed by heart teams at each site on the basis of consensus provincial indications. Referrals for lower volume and more complicated TAVR, including nontransfemoral access and valve-in-valve procedures, are concentrated at a single site. In-hospital and 30-day outcomes are reported. Results The median age was 83 years (interquartile range [IQR]: 78 to 87 years) and median STS score was 6% (IQR: 4% to 8%). Transfemoral access was performed in 499 (85.6%) cases and nontransfemoral in 84 (14.4%). Transcatheter valve-in-valve procedures in for failed bioprosthetic valves were performed in 43 patients (7.4%). A balloon-expandable valve was inserted in 386 (66.2%) and a self-expanding valve in 189 (32.4%). All-cause 30-day mortality was 3.5%. All-cause in-hospital mortality and disabling stroke occurred in 3.1% and 1.9%, respectively. Median length of stay was 3 days (IQR: 3 to 6 days), with 92.8% of patients discharged directly home. Conclusions This experience demonstrates the potential benefits of a regional system of care for TAVR. Excellent outcomes were demonstrated: most patients had short in-hospital stays and were discharged directly home.
Databáze: OpenAIRE